Report the ad
Ponatinib 15/30 mg Tablets in India for Targeted Cancer Therapy - Kolkata
Tuesday, 29 October, 2024
Item details
City:
Kolkata, West Bengal
Offer type:
Offer
Item description
Ponatinib 15/30 mg tablets play a vital role in targeted cancer therapy, particularly for chronic myeloid leukemia (CML) patients who possess resistant gene mutations. By inhibiting BCR-ABL tyrosine kinase mutations, including the difficult-to-treat T315I mutation, Ponatinib offers hope for those with limited treatment options. Ponatinib 15 / 30 mg in India, provides targeted action with improved outcomes. This innovative treatment is made accessible through Impomed Healthcare, supporting patients needing advanced cancer care solutions.
For more information visit:-httpswww.impomedhealthcare.com
For more information visit:-httpswww.impomedhealthcare.com
Related ads
Ponatinib 15/30 mg stands at the forefront of revolutionizing cancer treatment in India's oncology…
The introduction of ICLUSIG, (ponatinib tablets) has significantly improved the survival rate of…
Selpercatinib 40 & 80 mg in India is a targeted therapy for RET fusion-positive non-small cell lung…
Binimetinib 15 mg tablets provide advanced targeted therapy for melanoma, focusing specifically on…
Tucatinib 50 and 150 mg tablets offer a targeted approach to treating HER2-positive cancers…
Venetoclax 100 mg tablets are a targeted therapy designed to fight drug-resistant leukemia by…
Binimetinib 15 mg tablets offer a powerful option for treating melanoma, particularly for patients…
Sotorasib tablet also known by its brand name Lumakras, is a precision medicine specifically…
Selpercatinib 40 & 80 mg tablets offer precision medicine for patients with RET-positive cancers…
Regonat is an anti-cancer drug from Natco Pharma that includes Regorafenib as its active ingredient…
